Rheumatology 2000; 39: 1110-1113
© 2000 British Society for Rheumatology
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement*
Department of Rheumatology, University Hospital, Lund, Sweden
Objective. To study collagen metabolites in systemic sclerosis (SSc) and their relationship with clinical manifestations of the disease.
Methods. Forty-eight SSc patients, 13 with a diffuse form (dcSSc), 23 with a limited form (lcSSc) and 12 with suspected SSc not fulfilling the ACR criteria, and 31 healthy controls were examined. Serum concentrations of aminoterminal type III procollagen peptide (PIIINP), aminoterminal and carboxyterminal type I procollagen peptides (PINP and PICP) and cross-linked carboxyterminal telopeptide of collagen I (ICTP) were determined by radioimmunoassay.
Results. Increased serum concentrations of ICTP were found in SSc patients compared with controls. Distinctly higher levels of ICTP were observed in dcSSc than in lcSSc. High serum ICTP was correlated with skin score and acute phase reactants, and with reduced pulmonary function. Serum PIIINP concentration was elevated in both lcSSc and dcSSc.
Conclusion. Augmented collagen catabolism accompanies the increased collagen synthesis in SSc. Serum ICTP concentration is a marker of this feature and also reflects clinical severity.
KEY WORDS: Systemic scleroderma, Collagen metabolites, Collagen catabolism, Procollagen peptide, Telopeptide.
* Presented in part at the 27th Scandinavian Congress of Rheumatology, Aarhus, Denmark, June 1998 and at the ACR 62nd National Meeting, San Diego, California, USA, November 1998.
Correspondence to: A. Scheja, Department of Rheumatology, Lund University Hospital, S-221 85 Lund, Sweden.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R Hesselstrand, A Kassner, D Heinegard, and T Saxne COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker Ann Rheum Dis, September 1, 2008; 67(9): 1242 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hettema, D. Zhang, Y. Stienstra, P. N. H. Oomen, A. J. Smit, C. G. M. Kallenberg, and H. Bootsma Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankle Rheumatology, September 1, 2008; 47(9): 1409 - 1412. [Abstract] [Full Text] [PDF] |
||||

